These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10802320)

  • 1. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro.
    Nikodem D; Davidson E
    Mol Biochem Parasitol; 2000 Apr; 108(1):79-91. PubMed ID: 10802320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U; Epp C; Kauth CW; Lutz R; Long CA; Coulibaly B; Kouyaté B; Arevalo-Herrera M; Herrera S; Bujard H
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
    Uthaipibull C; Aufiero B; Syed SE; Hansen B; Guevara Patiño JA; Angov E; Ling IT; Fegeding K; Morgan WD; Ockenhouse C; Birdsall B; Feeney J; Lyon JA; Holder AA
    J Mol Biol; 2001 Apr; 307(5):1381-94. PubMed ID: 11292349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
    Guevara Patiño JA; Holder AA; McBride JS; Blackman MJ
    J Exp Med; 1997 Nov; 186(10):1689-99. PubMed ID: 9362529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism and epitope sharing between the alleles of merozoite surface protein-1 of Plasmodium falciparum among Indian isolates.
    Mamillapalli A; Sunil S; Diwan SS; Sharma SK; Tyagi PK; Adak T; Joshi H; Malhotra P
    Malar J; 2007 Jul; 6():95. PubMed ID: 17659072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.
    O'Donnell RA; de Koning-Ward TF; Burt RA; Bockarie M; Reeder JC; Cowman AF; Crabb BS
    J Exp Med; 2001 Jun; 193(12):1403-12. PubMed ID: 11413195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Plasmodium falciparum erythrocyte binding protein associated with the merozoite surface, PfDBLMSP.
    Wickramarachchi T; Cabrera AL; Sinha D; Dhawan S; Chandran T; Devi YS; Kono M; Spielmann T; Gilberger TW; Chauhan VS; Mohmmed A
    Int J Parasitol; 2009 Jun; 39(7):763-73. PubMed ID: 19367830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR; Kocken CH; White JH; Cowan GJ; Samuel K; Dubbeld MA; Voorberg-van der Wel A; Thomas AW; McBride JS; Arnot DE
    PLoS One; 2014; 9(1):e83704. PubMed ID: 24421900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA; Norazmi MN
    Parasitol Res; 2011 Apr; 108(4):887-97. PubMed ID: 21057812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U; Epp C; Hackett F; Blackman MJ; Bujard H
    Malar J; 2010 Mar; 9():77. PubMed ID: 20298576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of functional regions on Plasmodium falciparum EBA-175 by antibodies eluted from immune complexes.
    Sim BK
    Mol Biochem Parasitol; 1998 Sep; 95(2):183-92. PubMed ID: 9803411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies.
    de Koning-Ward TF; O'Donnell RA; Drew DR; Thomson R; Speed TP; Crabb BS
    J Exp Med; 2003 Sep; 198(6):869-75. PubMed ID: 12963693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal malaria immune experience affects acquisition of Plasmodium falciparum merozoite surface protein-1 invasion inhibitory antibodies during infancy.
    Dent A; Malhotra I; Mungai P; Muchiri E; Crabb BS; Kazura JW; King CL
    J Immunol; 2006 Nov; 177(10):7139-45. PubMed ID: 17082631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
    John CC; O'Donnell RA; Sumba PO; Moormann AM; de Koning-Ward TF; King CL; Kazura JW; Crabb BS
    J Immunol; 2004 Jul; 173(1):666-72. PubMed ID: 15210830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.
    Morgan WD; Lock MJ; Frenkiel TA; Grainger M; Holder AA
    Mol Biochem Parasitol; 2004 Nov; 138(1):29-36. PubMed ID: 15500913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA; Nickel B; Ciatto C; Grütter MG; Pöltl-Frank F; Rossi L; Siegler U; Robinson J; Kashala O; Patarroyo ME; Pluschke G
    Eur J Immunol; 2002 Dec; 32(12):3667-77. PubMed ID: 12516559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
    Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A malaria vaccine based on the polymorphic block 2 region of MSP-1 that elicits a broad serotype-spanning immune response.
    Cowan GJ; Creasey AM; Dhanasarnsombut K; Thomas AW; Remarque EJ; Cavanagh DR
    PLoS One; 2011; 6(10):e26616. PubMed ID: 22073118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.